HomeAI · summaries
Storia in 3 fonti
Regeneron, Sanofi tease potential expanded collaboration for Dupixent follow-ons
Regeneron & Sanofi discuss expanding partnership, potentially including Dupixent follow-ons. CEOs Schleifer & Garijo cite need to rebuild trust amid ongoing litigation.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
Booming Dupixent sales fuel Regeneron's biggest quarter since pandemic
A series of label expansions for Sanofi and Regeneron’s Dupixent, including its key 2024 FDA
- ·
endpoints.news
Regeneron, Sanofi tease potential expanded collaboration for Dupixent follow-ons
Regeneron & Sanofi discuss expanding partnership, potentially including Dupixent follow-ons. CEOs Schleifer & Garijo cite need to rebuild trust amid ongoing litigation.
